Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 218,008 | 674 | 1,151 | -488 | -5,199 |
| Depreciation Amortization | 23,312 | 14,488 | 6,608 | 22,418 | 16,603 |
| Income taxes - deferred | -223,065 | 0 | 0 | N/A | N/A |
| Accounts receivable | -5,194 | -4,142 | -9,066 | -19,242 | -14,080 |
| Other Working Capital | -14,417 | -8,517 | -13,473 | 19,874 | 17,404 |
| Other Operating Activity | 35,884 | 22,968 | 18,030 | 65,170 | 53,538 |
| Operating Cash Flow | $34,528 | $25,471 | $3,250 | $87,732 | $68,266 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -13,147 | -38,790 | -40,901 | 29,763 | 40,656 |
| PPE Investments | -38,720 | -29,348 | -14,108 | -89,801 | -67,180 |
| Net Acquisitions | -32,950 | -14,124 | -14,124 | -17,517 | -6,250 |
| Purchase Of Investment | -2,915 | -1,465 | -1,465 | -2,120 | -1,380 |
| Investing Cash Flow | $-87,732 | $-83,727 | $-70,598 | $-79,675 | $-34,154 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -118 | -85 | -43 | -185 | -136 |
| Common Stock Issued | 19,888 | 13,166 | 9,183 | 10,886 | 8,371 |
| Other Financing Activity | -6,198 | -6,217 | 0 | -74,487 | -73,469 |
| Financing Cash Flow | $13,572 | $6,864 | $9,140 | $-63,786 | $-65,234 |
| Beginning Cash Position | 167,171 | 167,171 | 167,171 | 222,900 | 222,900 |
| End Cash Position | 127,539 | 115,779 | 108,963 | 167,171 | 191,778 |
| Net Cash Flow | $-39,632 | $-51,392 | $-58,208 | $-55,729 | $-31,122 |
| Free Cash Flow | |||||
| Operating Cash Flow | 34,528 | 25,471 | 3,250 | 87,732 | 68,266 |
| Capital Expenditure | -38,720 | -29,348 | -14,108 | -89,801 | -67,180 |
| Free Cash Flow | -4,192 | -3,877 | -10,858 | -2,069 | 1,086 |